Invited commentaryNosology of psychoses in DSM-5: Inches ahead but miles to go
Section snippets
Role of funding source
This paper was supported in part by NIMH grant MH 78113.
Contributor
Dr. Matcheri S Keshavan MD is the sole author who wrote the manuscript.
Conflict of interest
There are no conflicts relevant to this manuscript.
Acknowledgments
I thank Dr. Rajiv Tandon for his valuable comments.
References (19)
- et al.
Genetics and intermediate phenotypes of the schizophrenia–bipolar disorder boundary
Neurosci. Biobehav. Rev.
(2010) - et al.
Brain gray matter phenotypes across the psychosis dimension
Psychiatry Res.
(2012) - et al.
A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale
Schizophr. Res.
(2011) - et al.
Reimagining psychoses: an agnostic approach to diagnosis
Schizophr. Res.
(2013) - et al.
Schizoaffective Disorder in the DSM-5
Schizophr. Res.
(2013) - et al.
Definition and description of schizophrenia in the DSM-5
Schizophr. Res.
(2013) - et al.
Catatonia in DSM-5
Schizophr. Res.
(2013) Diagnostic and Statistical Manual of Mental Disorders
(2013)- et al.
Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5
Schizophr. Res.
(2013)
Cited by (10)
Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery
2017, Neuroscience and Biobehavioral ReviewsCitation Excerpt :During and since the publication of DSM-5, there have been several issues raised and comments elicited. DSM-5 continues to be basically a categorical system for clinical use (Casey et al., 2013; Heckers et al., 2013; Hyman, 2007; Jablensky, 2013), and criteria are removed, changed or downplayed (Keshavan, 2013; Malaspina et al., 2014; Simpson, 2014; Tandon, 2013; Tandon et al., 2013; Volkow and O'Brien, 2007). In general, DSM caters to many and diverse end-users such as general clinicians, specialists, health service providers, insurance companies as well as researchers (Lecavalier, 2013; Malhi, 2013).
Evaluating clinicians’ representations of schizoaffective disorder
2017, Comprehensive PsychiatryCitation Excerpt :Although ICD-10's classification of SAD has also exhibited poor diagnostic outcomes, the ICD-11 Working Group on Schizophrenia and Other Primary Psychotic Disorders elected not to require a longitudinal assessment of symptom co-occurrence because they deemed it would be too difficult for many individuals to recall when they experienced psychosis and disturbed mood simultaneously [9]. Some have suggested that the changes in DSM-5 may provide some improvement in diagnostic reliability and utility, but the changes are insufficient to address SAD's diagnostic validity [8] considering there is little empirical evidence to differentiate SAD from SCZ and other constructs [2]. SAD's poor diagnostic outcomes could stem from its conceptual nature of encompassing psychotic and affective symptoms that could manifest in a variety of ways based on previous criteria [6,10,11].
Remembering psychiatry's core strengths while incorporating neuroscience
2015, Asian Journal of PsychiatryFrom DSM-IV-TR to DSM-5: Analysis of some changes
2014, International Journal of Clinical and Health PsychologyCitation Excerpt :In schizophrenia, as already claimed, diagnostic subtypes (catatonic, disorganized, paranoid, undifferentiated and residual types) had to be eliminated due to limited diagnostic stability, low reliability, and poor validity (APA, 2013c). The relevance given in diagnostic criteria to Schneiderian first-rank symptoms and the consideration of bizarre delusions, traditionally linked to schizophrenia, has disappeared, thereby gaining in specificity (Keshavan, 2013). There are no changes in the consideration of the minimum of indicators for Criterion A (at least two symptoms), but it is emphasized that at least one has to be a positive symptom: hallucinations, delusions, and/or disorganized speech.
Persistent Post-Concussive Psychiatric Problems
2019, Concussion and Traumatic Encephalopathy: Causes, Diagnosis, and Management